New cancer vaccine boosts survival rate, Moderna says – CBS News
There’s promising news about a possible melanoma vaccine made by Moderna and Merck. Moderna said a small study showed the vaccine significantly lowered patients’ risk of relapse or death. A larger study is planned for next year.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.